scholarly article | Q13442814 |
P356 | DOI | 10.1007/BF00263904 |
P698 | PubMed publication ID | 4053272 |
P2093 | author name string | J Russell | |
P A Reece | |||
I Stafford | |||
P G Gill | |||
P2860 | cites work | Pharmacokinetics of Ip cisplatin in refractory ovarian carcinoma. | Q33476440 |
Pharmacokinetic study of cis-dichlorodiammineplatinum(II) (DDP) in the beagle dog: thermodynamic and kinetic behavior of DDP in a biologic millieu | Q41442133 | ||
Urine analysis of platinum species derived from cis-dichlorodiammineplatinum(II) by high-performance liquid chromatography following derivatization with sodium diethyldithiocarbamate | Q66851558 | ||
Platinum concentrations in bile and plasma following rapid and 6-hour infusions of cis-dichlorodiammineplatinum(II) | Q67020046 | ||
Kinetics of cis-dichlorodiammineplatinum | Q67467904 | ||
Pharmacokinetic evidence for an enterohepatic circulation in a patient treated with cis-dichlorodiammineplatinum (II) | Q70650281 | ||
Renal handling of cis-diamminedichloroplatinum(II) | Q70658744 | ||
Sensitive high-performance liquid chromatographic assay for platinum in plasma ultrafiltrate | Q70791350 | ||
Mutagenic activity and identification of excreted platinum in human and rat urine and rat plasma after administration of cisplatin | Q71230742 | ||
Evaluation of reductive amperometric detection in the liquid chromatographic determination of antineoplastic platinum complexes | Q71232376 | ||
Mechanisms of renal excretion of cisdichlorodiamine platinum | Q71237567 | ||
Nonlinear renal elimination kinetics of methotrexate due to saturation of renal tubular reabsorption | Q71324292 | ||
The mechanism of renal clearance of cisplatin (cis-dichlorodiammine platinum ii) and its modification by furosemide and probenecid | Q71840512 | ||
P433 | issue | 3 | |
P304 | page(s) | 295-299 | |
P577 | publication date | 1985-01-01 | |
P1433 | published in | Cancer Chemotherapy and Pharmacology | Q326137 |
P1476 | title | Nonlinear renal clearance of ultrafilterable platinum in patients treated with cis-dichlorodiammineplatinum (II). | |
P478 | volume | 15 |
Q69206316 | A model for ultrafilterable plasma platinum disposition in patients treated with cisplatin |
Q33487664 | A phase I trial of 5-day continuous infusion cisplatin and interferon alpha |
Q38702252 | Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2 |
Q33375771 | Clinical Pharmacokinetics of Carboplatin |
Q53043144 | Effect of methotrexate on the pharmacokinetics and renal excretion of cisplatin. |
Q69934312 | Evaluation of the effect of furosemide on ultrafilterable platinum kinetics in patients treated with cis-diamminedichloroplatinum |
Q42061579 | Influence of infusion time on unchanged cisplatin disposition in patients with ovarian cancer |
Q71581734 | Long-term pharmacokinetic behavior of platinum after cisplatin administration |
Q30446860 | Membrane transporters as mediators of Cisplatin effects and side effects |
Q39768346 | Pharmacokinetics of anticancer drugs in children |
Q44888513 | Pharmacokinetics of unchanged carboplatin (CBDCA) in patients with small cell lung carcinoma |
Q39098252 | Xenobiotic transporters and kidney injury |